The Quiet Revolution Overthrowing The Broken Cancer Treatment Model
Updated
Wisconsin Senator Ron Johnson held what is being called a ‘high-stakes’ hearing on June 3rd, which made history as the first public scientific inquiry to investigate the cancer-causing mechanisms of a public health vaccine intervention on Capitol Hill.
Far from safe and effective, the COVID shot is once again taking center stage for its potential harms.
The alarming testimony included Professor of Oncology at St George’s University of London, Dr. Angus Dalgleish, who began seeing colorectal cancers in his patients, along with similar reports from his fellow surgeons, presenting as late stage four (not stage one or two) after the experimental Covid injections began.
He also noted the cancers were early in patients in their 20s, 30s, and 40s “in a way that we have not seen before,” prompting him to begin researching as he testified:
“Looking at the literature as to why this could be […] there are remarkable at least a dozen mechanisms where messenger RNA can insert into the DNA and activate oncogenes. And more importantly, and especially the long term, they can suppress the suppressor networks, which means if a cancer is starting to evolve, it would normally be maintained, uh, controlled and this mechanism is being prevented.”
Wafik El-Deiry, MD, PhD, FACP, is an American Cancer Society Professor and tenured Professor at Brown University who served as an expert on a HHS Committee on Immunization Practices Working Group on Covid immunizations.
According to his testimony, he “looked into everything we know about cancer and Covid infection and Covid vaccination, and by the fall found nearly 70 papers describing more than 300 reported cancer cases from 27 countries following one or more Covid mRNA vaccine injections.”
Beyond Sen. Johnson’s hearing, a quiet, multifaceted revolution is working to rewrite the rules of cancer and its treatments.
On May 13th, federal leads Kennedy (HHS), Bhattacharya (NIH), along with senior officials from the National Cancer Institute (NCI), held a scientific symposium and executive roundtable calling for a “moonshot” focused on the role of the microbiome for cancer prevention and care.
The move represents a departure from the mechanistic and isolationist legacy cancer treatment paradigm to favor a more interconnected, holistic view of the human body and disease progression.
Another paradigm switch away from the isolationist view of cancer is the growing understanding that one’s immune system is central to cancer treatment and care.
An idea encapsulated brilliantly by cancer researcher and surgeon Patrick Soon-Shiong, who critiqued the approach of modern oncologists during his appearance with Tucker Carlson.
Along with the big picture shifts in cancer understanding, individual therapeutic models have also come, rejecting the conventional ‘cut, poison, and burn‘ options.
A landmark 2020 paper found that honeybee venom and its major component melittin potently induce cell death, particularly in the aggressive triple-negative and HER2-enriched breast cancer subtypes.
The last five years have built on the findings, now amassing 40 papers outlining the promise of a potential honeybee venom breast cancer treatment modality and its overall anticancer properties.
In Japan, nature continues to be the inspiration as a healing source. Researchers from Japan’s Advanced Institute of Science and Technology (JAIST), thinking outside the box, have discovered the cancer tumor-eliminating effects of a gut microbe (bacteria) from amphibians and reptiles.
In their recent paper, the researchers state:
“To our knowledge, this represents the first reported demonstration that a naturally occurring gut bacterium isolated from a wild host organism achieved complete tumor regression following a single intravenous administration.”
Meanwhile, repurposed drugs are experiencing a resurgence due to their effects on cancer regression. Earlier this year, the NCI, alongside NIH director Dr. Bhattacharya, announced it would launch a new study initiative to examine the antiparasitic medication-turned-COVID therapy ivermectin.
Investigational studies and accounts from doctors and patients are signaling ivermectin may be an effective anticancer drug therapy.
In the fight to understand cancer, there appears to be no one-size-fits-all cure, and the shifting emphasis shows a greater respect for the holistic nature of the body’s intelligence. A renewed respect for the safeguarding effects of our immune system, alongside less toxic and safer therapeutic alternatives, shines as a beacon of hope for medical researchers and oncologists who have lost their way.
In the meantime, both Moderna and BioNTech are racing to develop cancer vaccines before investigations can spotlight if indeed their rushed Covid vaccines kicked off a cancer surge in the population.
A revolution in cancer therapy is desperately needed. New statistics out recently from the National Cancer Institute show incidence rates among Americans under age 50 jumped 6.4% between 2021 and 2023. A window of opportunity exists with Kennedy at HHS and Dr. Bhattacharya leading NIH, for business as usual to be disrupted within government and the revolving doors of the pharmaceutical industry, for something greater to emerge.